Target Price | $22.50 |
Price | $18.68 |
Potential |
20.45%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Avanos Medical, Inc. 2025 .
The average Avanos Medical, Inc. target price is $22.50.
This is
20.45%
register free of charge
$25.00
33.83%
register free of charge
$20.00
7.07%
register free of charge
|
|
A rating was issued by 3 analysts: 1 Analysts recommend Avanos Medical, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Avanos Medical, Inc. stock has an average upside potential 2025 of
20.45%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 673.30 | 685.43 |
17.89% | 1.80% | |
EBITDA Margin | 16.11% | 16.19% |
1.88% | 0.47% | |
Net Margin | -9.08% | 0.60% |
251.38% | 106.61% |
3 Analysts have issued a sales forecast Avanos Medical, Inc. 2024 . The average Avanos Medical, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Avanos Medical, Inc. 2024 . The average Avanos Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.33 | 0.09 |
224.30% | 106.77% | |
P/E | 207.56 | |
EV/Sales | 1.42 |
Based on analysts' sales estimates for 2024, the Avanos Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Avanos Medical, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.